國光生物科技股份有限公司 News Releases

Adimmune Corporation reported a basic EPS of -0.57 NTD and a net loss of 330 million NTD for Q4 2025… · 2025-12-01

Adimmune Corporation, a company in the biotechnology and medical care industry, announced its financ… · 2026-03-01

Adimmune Corporation, a company in the biotechnology and medical care industry, announced its financ… · 2026-03-01

Adimmune Corporation, a company in the biotechnology and medical care industry, announced its financ… · 2026-03-01

Adimmune Corporation, a company in the biotechnology and medical care industry, announced its financ… · 2026-03-01

Adimmune Corporation reported a basic EPS of -0.57 NTD and a net loss of 330 million NTD for Q4 2025… · 2025-12-01

Adimmune Corporation, a company in the biotechnology and medical care industry, announced its financ… · 2026-03-01